Our data support the idea that NUPR1 activation is strongly involved in protecting the cell against programmed cell death by both apoptosis and programmed necrosis, and therefore, targeting NUPR1 protein in cancer appears to be a promising tool as an anticancer therapeutic strategy. The gene discussed is NUPR1; the disease is cancer.